BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BBO-8520 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BBO-8520\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06343402-2385@assetmemo.bio
DTSTAMP:20261121T005845Z
DTSTART;VALUE=DATE:20310430
DTEND;VALUE=DATE:20310501
SUMMARY:BBO-8520: Phase 1 readout est. (NCT06343402)
DESCRIPTION:BBO-8520\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Open-l
 abel Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung
  Cancer\nEstimated primary completion: April 2031. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/bbo-8520#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT06343402
URL:https://assetmemo.bio/drug/bbo-8520#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
